Merck, the drug maker, announced this week that it would payout over $688 million to settle lawsuits brought by its shareholders, including a number of pension funds that alleged large sums of money were lost due to the handling of results from a clinical trial. The results caused Vytorin’s prescriptions to plummet. Vytorin is the […]
Vytorin Maker Settles Lawsuits is a post from: Ticker Report
The post Vytorin Maker Settles Lawsuits appeared first on Ticker Report.
